Aptose Biosciences Inc. (APTOF)
OTCMKTS · Delayed Price · Currency is USD
1.250
+0.060 (5.04%)
Aug 22, 2025, 9:30 AM EDT
Aptose Biosciences Market Cap
Aptose Biosciences has a market cap or net worth of $2.92 million as of August 25, 2025. Its market cap has decreased by -70.65% in one year.
Market Cap
2.92M
Enterprise Value
13.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.25
Market Cap Chart
Since May 31, 1994, Aptose Biosciences's market cap has decreased from 34.16M to 2.92M, a decrease of -91.47%. That is a compound annual growth rate of -7.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 2.92M | -78.55% |
| Dec 31, 2024 | 13.59M | -32.53% |
| Dec 29, 2023 | 20.15M | -62.12% |
| Dec 30, 2022 | 53.19M | -56.27% |
| Dec 31, 2021 | 121.64M | -68.80% |
| Dec 31, 2020 | 389.84M | -9.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 632.06M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 368.43M |